Wednesday, February 11, 2009

Genzyme Corporati

Power pick of the day: Genzyme Corporati (GENZ) trading at USD 72.00.

  • 52-wk range: USD 57.61 - 83.97
  • EPS: 1.475
  • P/E Ratio: 48.26
  • Market Cap: 19.477B
  • Average Daily Volume: 3,090,920

Stock Chart

Recent News

Genzyme Beats Street, Guides Flat TheStreet.com Strong Fourth Quarter for Genzyme Concludes Productive Year MarketWatch (press release) Genzyme Q4 profit rises; Backs FY09 revenues outlook - Quick Facts RTT News Trading Markets (press release) - RTT Newsall 10 news articles [via Bloomberg on 2009-02-11T14:37:38Z]

Genzyme 4th-qtr profit rises on higher drug sales Reuters - 12 minutes ago 11 (Reuters) - Genzyme Corp (GENZ.O) said on Wednesday its fourth-quarter earnings rose nearly 10 percent as it held down costs and generated higher sales [via Reuters on 2009-02-11T15:05:13Z]

ProLogis Guides Inline Trading Markets (press release) Waste Connections Gudies Inline Trading Markets (press release) Charles River Labs Guides Below Estimates Trading Markets (press release) all 153 news articles [via Trading Markets (press release) on 2009-02-11T14:24:21Z]

Genzyme Q4 likely to meet expectations - Earnings Preview Trading Markets (press release), CA - 7 hours ago (RTTNews) - Biotechnology company Genzyme Corp. (GENZ | Quote | Chart | News | PowerRating) is expected to announce fourth-quarter results before the market [via Earnings Preview - Trading Markets (press release) on 2009-02-11T07:42:10Z]

Harsh medicine Boston Business Journal, USA - 4 hours ago Exact Sciences had long been in conversations with Genzyme%20Corp">Cambridge’s Genzyme Corp. (Nasdaq: GENZ) about cross-licensing products, [via Boston Business Journal on 2009-02-11T11:15:53Z]

Genzyme 4Q Net Up 9.8%; Forecasts Big '09 Myozyme Sales Jump EasyBourse.com, France - 19 minutes ago DOW JONES NEWSWIRES Genzyme Corp. (GENZ) posted a 9.8% rise in fourth-quarter net income, helped by surging sales of its Myozyme treatment for Pompe disease [via EasyBourse.com on 2009-02-11T14:58:21Z]

EXACT Sciences Announces Issuance Of Key Patent Covering Vimentin [via Bizjournals.com on 2009-02-06T19:21:45Z]

Genzyme Center Wins Prestigious Architecture Award WELT ONLINE, Germany - Feb 3, 2009 Genzyme Corp. (NASDAQ: GENZ) announced today that its global corporate headquarters, Genzyme Center, is the 2008 recipient of the Harleston Parker Medal, [via WELT ONLINE on 2009-02-03T18:33:36Z]

Exact Sciences gets $24.5 million in Genzyme deal Forbes Genzyme buys some assets, 3 mln shrs of Exact Sciences Reuters EXACT Sciences Announces Strategic Transaction with Genzyme [via Boston Herald on 2009-01-28T00:26:00Z]

WELT ONLINE, Germany - Feb 10, 2009 For online information about Dyax Corp., please visit www.dyax.com. This press release contains forward-looking statements, including statements regarding [via WELT ONLINE on 2009-02-10T11:42:00Z]

Mal: "I would appreciate it if one person on this boat did not assume I was an evil, lecherous hump." Zoe: "Nobody's saying that, sir." Wash: "Yeah, we're mostly just giving each other significant glances and laughing incessantly. Is that cider?"

No comments: